Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · Real-Time Price · USD
1.150
0.00 (0.00%)
Feb 21, 2025, 4:00 PM EST - Market closed
Cytosorbents Employees
Cytosorbents had 186 employees as of December 31, 2023. The number of employees decreased by 12 or -6.06% compared to the previous year.
Employees
186
Change (1Y)
-12
Growth (1Y)
-6.06%
Revenue / Employee
$202,901
Profits / Employee
-$100,376
Market Cap
62.88M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
CTSO News
- 7 weeks ago - CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2024 Product Revenue - GlobeNewsWire
- 2 months ago - CytoSorbents to Host Investor Meetings in San Francisco During J.P. Morgan Healthcare Conference Week - GlobeNewsWire
- 3 months ago - CytoSorbents And Converge Biotech Announce Strategic Partnership to Expand Sepsis and Critical Care Treatment with CytoSorb in India - GlobeNewsWire
- 3 months ago - Cytosorbents Corporation (CTSO) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - CytoSorbents Submits DrugSorb-ATR Marketing Application to U.S. FDA to Reduce the Severity of Bleeding in Heart Bypass Surgery Patients on the Blood Thinner Ticagrelor and Provides Business Update - GlobeNewsWire
- 6 months ago - CytoSorbents to Present at the H.C. Wainwright 26ᵗʰ Annual Global Investment Conference - GlobeNewsWire
- 6 months ago - CytoSorbents Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 months ago - Cytosorbents Corporation (CTSO) Q2 2024 Earnings Call Transcript - Seeking Alpha